A personalized approach with Prosigna.
New data where 2 out of 3 women with hormone positive breast cancer (HER2-negative) over 40 years of age, could safely skip chemotherapy thanks to the genetic test Prosigna. The survival rates were almost identical. This also included women who where higher risk such as stage 3 and with up to 9 positive lymph nodes.
https://www.tiktok.com/@drlemmocancer/video/7646924244118457607?lang=en
https://www.bbc.com/news/articles/c2325j0xk1vo